Oncology
GLP-1 Receptor Agonists and Breast Cancer Risk Reduction
The metabolic landscape of oncology is rapidly evolving, driven by an expanding understanding of how systemic metabolic dysfunction
Rayan Salih · July 22, 2026 · 8 min
Living with Breast Cancer
Stories from people navigating Breast Cancer — diagnosis, treatment, caregiving, and the ordinary days in between.
13 stories
Oncology
Beyond the Prescription Pad: Breast Cancer Survivorship via Combined Lifestyle Interventions
For decades, the oncology landscape has viewed lifestyle modification as a pleasant, well-intentioned afterthought—a supportive measure for general
Rayan Salih · 10 min read
Oncology
ctDNA in Early Breast Cancer: Prognostic Power vs Clinical Actionability
Circulating tumor DNA (ctDNA) is a blood-based signal that is drawing a lot of attention in early breast
Dr. Abu Bakar · 6 min read
Oncology
Can Carboplatin Be Safely Omitted in Neoadjuvant HER2-Positive Breast Cancer? Evidence, Patient Selection, and Practice Impact
For patients with neoadjuvant HER2+ breast cancer, clinicians are increasingly reconsidering whether carboplatin a platinum chemotherapy drug sometimes
Dr. Abu Bakar · 7 min read
Oncology
T-DXd Tolerability in Community-Treated HER2-Low Metastatic Breast Cancer: What Real-World Practice Is Showing
Trastuzumab Deruxtecan (T-DXd) is now increasingly emerging as the preferred choice for HER2-low metastatic breast cancer patients, and
Dr. Abu Bakar · 9 min read
Oncology
Ultra‑Hypofractionated Radiation Therapy for Locally Advanced Breast Cancer
Shorter, higher‑dose radiation therapy schedules are being explored for people with locally advanced breast cancer, and early experience
Dr. Abu Bakar · 6 min read
Women's Health
IOA-244(p110δ PI3K) Stops Breast Tumor Progression Mono/Combo Tx
The experimental compound IOA-244 is targeted to the p110δ isoform of phosphoinositide 3‑kinase (PI3K) and is active in
Rayan Salih · 2 min read
Oncology
THP Noninferior To TCbHP For pCR In HER2+ Early Breast Cancer
The comparison of management of HER2-positive early breast cancer suggests that the addition of carboplatin to any backbone
Rayan Salih · 3 min read
Oncology
FDA Priority Review for Post-Neoadjuvant T-DXd in HER2+ Early BC
On March 9, 2026, researchers of early stage HER2-positive breast cancer learned more recent information on the development
Rayan Salih · 3 min read
Oncology
Why Breast Cancer Is Increasing In Younger Women, Explained
The growing numbers of young women with breast cancer, means that prevention and screening programs, as well as
Dr. Abu Bakar · 16 min read
Oncology
Medically-Induced Menopause: Implications for Breast Cancer
Treatment-induced menopause (TIM) is an under-recognized health outcome for women with breast cancer.
Dr. Abu Bakar · 11 min read
Oncology
Medicaid Expansion Prevents Thousands Of Breast Cancer Deaths
Recent analyses and policy conversations point to a clear link between Medicaid expansion and improved outcomes for people
Rayan Salih · 8 min read
Oncology
Importance of Biopsy in Suspected Metastatic Breast Cancer
Why It Matters In order to best understand this patient’s illness, a biopsy is important.
Dr. Abu Bakar · 10 min read
Other conditions
One story a day
The story of the day, in your inbox
One health journey each morning — no advice, no alarm, just company for the road.